Pharmaniaga hopes for better performance from Indonesia


Pharmaniaga is poised to fulfil its obligation to supply 12 million Sinovac vaccine doses to the Federal Government in three months (by June or July)

KUALA LUMPUR: Pharmaniaga Bhd hopes Indonesia's measures to curb the Covid-19 pandemic would mitigate the negative impact on the company’s operations in the country and its overall performance in the current financial year 2021 (FY2021).

Chief financial officer Norai'ni Mohamed Ali said the Indonesian government has imposed stringent control measures since the second half of 2019.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

SD Guthrie’s latest tie-up a timely venture
Indonesian arm of local retail player MR DIY climbs on market debut
Minimal correction expected for Bursa
United Malacca’s net profit doubles in 2Q25
DRG payment system poses risk to hospital profit margins
Pentamaster to delist HK unit for 54 sen a share
EcoWorld’s industrial park deal a ‘win-win’ for all
Export growth likely to sustain next year
Scientex property unit to drive earnings
VW nears deal with unions to keep plants open

Others Also Read